Bernadette Tosti, Chief Product Office for ProofPilot, draws on her long wealth of clinical research experience to discuss best practices to validate new digital tools for decentralized clinical trials.
Bernadette Tosti, Chief Product Office for ProofPilot, draws on her long wealth of clinical research experience to discuss best practices to validate new digital tools for decentralized clinical trials. She also shares with co-hosts Nelia Padilla and Jefferson Smith the future questions about clinical research that she beleives need to be answered.
Dr. Isaac Rodriguez-Chavez is a pioneer in the field of clinical research. He joins the podcast to explain how important the twin concepts of digitization and customization are for designers of decentralized clinical trials--providing necessary tools is as important as responding to the needs of the patient. Dr. Rodriguez-Chavez also addresses challenging questions about the future of clinical research.
Paul Rude from Fierce Strategy + Creative discusses health care leadership strategies, the revolutionary impact of patient-owned health information, and the need to meet patients where they're at to recruit for clinical research. (35 minutes)
Paul Rude from Fierce Strategy + Creative discusses health care leadership strategies, the revolutionary impact of patient-owned health information, and the need to meet patients where they're at to recruit for clinical research.
Joseph Kim, Chief Strategy Officer of ProofPilot, discusses how clinical research can be unnecessarily wordy and complicated. Different interpretations of clinical research protocols bogs the process down, creating obstacles to capture data. Joseph proposes automating clinical research protocols as a solution to these issues.
Joseph Kim, Chief Strategy Officer of ProofPilot, discusses how clinical research can be unnecessarily wordy and complicated. Different interpretations of clinical research protocols bogs the process down, creating obstacles to capture data. Joseph proposes automating clinical research protocols as a solution to these issues.
Health care entrepreneurial executive and behavioral epidemiologist Dr. Kate Wolin joins the podcast to discuss using personalized technology to manage human behavior in clinical research.
Health care entrepreneurial executive and behavioral epidemiologist Dr. Kate Wolin joins the podcast to discuss using personalized technology to manage human behavior in clinical research.
Sylvia Baedorf Kassis, Program Manager at the Multi-Regional Clinical Trials of Brigham and Women's Hospital and Harvard, discusses her experience optimizing clinical research and how innovations in other sectors can be applied to the clinical research process.
Sylvia Baedorf Kassis, Program Manager at the Multi-Regional Clinical Trials of Brigham and Women's Hospital and Harvard, discusses her experience optimizing clinical research and how innovations in other sectors can be applied to the clinical research process.
Dr. Nita Vengeepuram from Mt. Sinai School of Medicine's Institute for Health Equity Research provides insights as to how increased community engagement and participation improves clinical research.
Dr. Nita Vangeepuran is the Co-Director of Community Engagement at Mt. Sinai School of Medicine's Institute of Health Equity Research. She discusses the importance of why expanding community involvement with clinical research is not only important to secure funding but also have improved and targeted results. Dr. Vangeepuran also shares her thoughts on the future of clinical research, including personalized medicine and data-gathering.
Lisa Hepner, director / producer of "The Human Trial" documentary, discusses her film and shares what she learned about the struggles faced by clinical trail participants and by drug companies seeking to raise the necessary funds for a successful clinical trail.
"The Human Trial" is a documentary that follows clinical trial participants as they assist in a cure for diabetes. Producer and director Lisa Hepner discusses her interest in capturing the clinical research process on film, including the struggles faced by both the participants and also by drug manufacturing company ViaCyte to secure the necessary funding to complete the research.
Dr. Irfan Khan emphasizes the need to maximize the research patient experience as the last great opportunity to accelerate the current system of drug development.
Dr. Irfan Khan explains how clinical research start-ups that adopt a patient centric approach are able to quickly scale up and find success.
Dr. Irfan Khan explains Circuit Clinical's patient voice and patient insight approach, increasing engagement with patients to provide feedback on their health care experience--and how this approach should be applied to clinical research.
Patient centricity means putting the patient first in an open and sustained engagement in clinical research. Dr. Irfan Khan, Founder and CEO of Circuit Clinical, explains why patients in the health care system should be viewed as consumers and should be provided the best experience possible, improving the clinical research experience.
Dr. Irfan Khan is the founder and CEO of Circuit Clinical, one of the largest research organizations in the United States. In this discussion, Dr. Khan discusses the necessary steps to create a complex research ecosystem that maximizes patient centrcity and increases trust and transparency for participants in clinical research.
